NALP3 inflammasome functional polymorphisms and gout susceptibility

Cell Cycle

Volumn 8, Issue 1, 2009, Pages 27-30

  Miao, Zhi Min ^a   Zhao, Shi Hua ^a   Yan, Sheng Li ^a   Li, Chang Gui ^a   Wang, Yan Gang ^a   Meng, Dong Mei ^a   Zhou, Li ^b,c   Mi, Qing Sheng ^b,c  

^a QINGDAO UNIVERSITY   (China)

^b HENRY FORD HOSPITAL   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Gout; Hyperuricemia; Inflammasome; NALP3; Susceptibility

Indexed keywords

CASPASE; CRYOPYRIN; INTERLEUKIN 1BETA; URATE; CARRIER PROTEIN; URIC ACID;

AUTOINFLAMMATORY DISEASE; CYTOKINE PRODUCTION; DISEASE MARKER; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC MARKER; GOUT; HUMAN; NONHUMAN; SHORT SURVEY; SIGNAL TRANSDUCTION; ARTICLE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; METABOLISM;

CARRIER PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GOUT; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; POLYMORPHISM, GENETIC; URIC ACID;

EID: 60749136794     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.1.7325     Document Type: Short Survey

References (41)

1. Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol 2007; 3:443-9.
2. Terkeltaub R. Gout in 2006: the perfect storm. Bull NYU Hosp Jt Dis 2006; 64:82-6.
3. Falasca GF. Metabolic diseases: gout. Clin Dermatol 2006; 24:498-508.
4. Zaka R, Williams CJ. New developments in the epidemiology and genetics of gout. Curr Rheumatol Rep 2006; 8:215-23.
5. Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin North Am 2006; 32:275.
6. Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol 2006; 18:199-203.
7. Masseoud D, Rott K, Liu-Bryan R, Agudelo C. Overview of hyperuricaemia and gout. Curr Pharm Des 2005; 11:4117-24.
8. Taniguchi A, Kamatani N. Control of renal uric acid excretion and gout. Curr Opin Rheumatol 2008; 20:192-7.
9. Shima Y, Teruya K, Ohta H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006; 79:2234-7.
10. Vazquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S, varado-Romano V, Pozo-Molina G, Burgos-Vargas R. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 2007; 46:215-9.
11. Miao ZM, Zhao SH, Wang YG, Li CG, Wang ZC, Chen Y, Chen XY, Yan SL. Epidemiological survey of hyperuricemia and gout in coastal areas of Shandong province. Chin J Endocrinol Metab 2006; 22:421-5.
12. Chen ML, Huang CM, Tsai CH, Tsai FJ. Interleukin-1beta gene polymorphisms in Taiwanese patients with gout. Rheumatol Int 2005; 25:179-82.
13. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425:516-21.
14. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, Akira S, Rock KL. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006; 116:2262-71.
15. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005; 174:5016-23.
16. Roberge CJ, Grassi J, De MR, Frobert Y, Lussier A, Naccache PH, Poubelle PE. Crystalneutrophil interactions lead to interleukin-1 synthesis. Agents Actions 1991; 34:38-41.
17. Di Giovine FS, MALAWISTA SE, Nuki G, Duff GW. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 1987; 138:3213-8.
18. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237-41.
19. Verma D, Lerm M, Blomgran JR, Eriksson P, Soderkvist P, Sarndahl E. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases? Arthritis Rheum 2008; 58:888-94.
20. Omi T, Kumada M, Kamesaki T, Okuda H, Munkhtulga L, Yanagisawa Y, Utsumi N, Gotoh T, Hata A, Soma M, Umemura S, Ogihara T, Takahashi N, Tabara Y, Shimada K, Mano H, Kajii E, Miki T, Iwamoto S. An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies gene expression and is associated with essential hypertension. Eur J Hum Genet 2006; 14:1295-305.
21. Van LJ, Nimmo ER, Russell RK, Drummond HE, Smith L, Anderson NH, Davies G, Arnott ID, Wilson DC, Satsangi J. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. Hum Mol Genet 2007; 16:2175-86.
22. McGovern DP, Butler H, Ahmad T, Paolucci M, van Heel DA, Negoro K, Hysi P, Ragoussis J, Travis SP, Cardon LR, Jewell DP. TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology 2006; 131:1190-6.
23. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961; 54:452-60.
24. Kohn NN, Hughes RE, McCarty DJ Jr, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome" II. Identification of crystals. Ann Intern Med 1962; 56:738-45.
25. Malawist SE, Seegmiller JE. The effect of pretreatment with colchicine on the inflammatory response to microcrystalline ureate: a model for gouty inflammation. Ann Intern Med 1965; 62:648-57.
26. Giamarellos-Bourboulis EJ, Mouktaroudi M, Bodar E, van d V, Kullberg BJ, Netea MG, van der Meer JW. Crystals of monosodium urate monohydrate enhance LPS-induced release of interleukin-1{beta} by mononuclear cells through a caspase-1 mediated process. Ann Rheum Dis 2008.
27. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005; 52:2936-46.
28. So A, De ST, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007; 9:28.
29. Murakami Y, Akahoshi T, Hayashi I, Endo H, Hashimoto A, Kono S, Kondo H, Kawai S, Inoue M, Kitasato H. Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. Arthritis Rheum 2003; 48:2931-41.
30. Ogura Y, Sutterwala FS, Flavell RA. The inflammasome: first line of the immune response to cell stress. Cell 2006; 126:659-62.
31. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006; 7:1250-7.
32. Mariathasan S. ASC, Ipaf and Cryopyrin/Nalp3: bona fide intracellular adapters of the caspase-1 inflammasome. Microbes Infect 2007; 9:664-71.
33. Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 2008; 4:34-42.
34. Petrilli V, Martinon F. The inflammasome, autoinflammatory diseases and gout. Joint Bone Spine 2007; 74:571-6.
35. Masters SL, Lobito AA, Chae J, Kastner DL. Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr Opin Allergy Clin Immunol 2006; 6:428-33.
36. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17:586-99.
37. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29:301-5.
38. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004; 364:1779-85.
39. Hoffman HM, Gregory SG, Mueller JL, Tresierras M, Broide DH, Wanderer AA, Kolodner RD. Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum Genet 2003; 112:209-16.
40. Razmara M, Srinivasula SM, Wang L, Poyet JL, Geddes BJ, DiStefano PS, Bertin J, Alnemri ES. CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J Biol Chem 2002; 277:13952-8.
41. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002; 277:21119-22.